What The Study Did:
Testimonials posted on a social media site were analyzed to examine whether individuals are using the cannabis-derived chemical compound cannabidiol (CBD) in an attempt to treat diagnosable conditions that have evidence-based therapies.
John W. Ayers, Ph.D., M.A., of the University of California, San Diego, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
JAMA Network Open:
JAMA Network Open
is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-10/jn-ecu101320.php